MindMed Advances 18-MC, Potential Treatment for Opioid Addiction, Into Further Clinical Testing

Posted by:

[ad_1]

18-MC is a proprietary, non-hallucinogenic molecule, based on the psychedelic ibogaine. In extensive nonclinical testing, 18-MC has shown promise …

[ad_2]

Source link

Continue Reading →
0

Join Claudio Naranjo at the Global Ibogaine Conference 2016

Posted by:



Claudio Naranjo will give a keynote about Ibogaine, his early day experiments and ibogaine’s therapeutic potential, at the Global Ibogaine Conference, Tepoztlan, Mexico, March 14-16 of 2016. Don’t miss this event! www.ibogaineconference.org

source

Continue Reading →
0

Claudio Naranjo: The Early Days’ Ibogaine Experiments

Posted by:



Interview with the Chilean Psychiatrist Claudio Naranjo about his clinical experiments in the 60s with Ibogaine; his findings, observations on therapeutic potential and phenomenology, etc.

Interview conducted in Mexico, April 2014

source

Continue Reading →
0
UA-77446339-1